MAPT and Alzheimer disease: A CSF biomarker pattern similar to that in Alzheimer's disease, with decreased CSF amyloid beta 1-42 fragment (Aβ1-42) and increased CSF total tau (t-tau) [20,21], has been reported in patients with ADC in one study [22].